Vascular Surgical Antibiotic Prophylaxis Study (VSAPS)

Abstract

This prospective, randomized study was performed at a single institution. Low-risk patients undergoing elective vascular procedures were enrolled (August 2007 to June 2009). Participants were randomized into 3 separate arms. They received cefazolin, cefazolin + vancomycin, or cefazolin + daptomycin prior to surgery. In total, 169 patients were included in the analysis. Mean age was 64 (range, 26-85), and the patients’ comorbidities were similar across all groups. Only Szilagyi II and III infections were analyzed. Any infection/methicillin-resistant Staphylococcus aureus (MRSA) infections was seen in 8 (12.9%)/2 (3.23%) in the cefazolin group, 7 (12.5%)/4 (7.14%) in the cefazolin + vancomycin group, and 2 (3.92%)/(0%) in the cefazolin + daptomycin group. In this study, population of low-risk patients undergoing elective vascular procedures, there was a trend toward fewer infectious complications in the cefazolin + daptomycin group. Adding anti-MRSA agents to the current standard prophylaxis regimen does not appear to reduce the incidence of MRSA infection in low-risk patients.

Keywords

infection MRSA surgical site

Get full access to this article

View all access options for this article.

References

Bandyk DF Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008;21(3): 119-123.

Kaiser AB , Clayson KR , Mulherin JL Jr , et al. Antibiotic prophylaxis in vascular surgery. Ann Surg. 1978;188(3):283-289.

Gilbert DN , Moellering RC Jr , Eliopoulos GM , Sande MA The Sanford Guide to Antimicrobial Therapy. ISBN: 1930808534; 2006.

Taylor MD , Napolitano LM Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalance. Surg Infect (Larchmt ). 2004;5(2):180-187.

Stone PA , Back MR , Armstrong PA , et al. Evolving microbiology and treatment of extracavitary prosthetic graft infections. Vasc Endovascular Surg. 2008;42(6):537-544.

SAS 9.2. Cary, NC: SAS Institute, Inc.

Surgical Care Improvement Project. MedQIC . https://www.qualitynet.org; January 2010.

Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1999.

Weber SG , Huang SS , Oriola S. , et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control. 2007;35(2):73-85.

10.

Diekema DJ , Edmond MB Look before you leap: active surveillance for multidrug-resistant organisms . Clin Infect Dis. 2007; 44(8):1101-1107.

11.

Malde DJ , Abidia A. , McCollum C. , Welch M. The success of routine MRSA screening in vascular surgery: a nine year review . Int Angiol. 2006;25(2):204-208.

12.

Zanetti G. , Goldie SJ , Platt R. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery. Emerg Infect Dis. 2001; 7(5):820-827.

13.

Harbath S. , Fankhauser C. , Schrenzel J. , et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients . J Am Med Assoc. 2008;299(10):1149-1157.

14.

Park C. , Hsu C. , Neelakanta G. , et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87(7): 1031-1036.

15.

Furnary AP , Wu Y. , Bookin SO Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(2):21-33.

16.

Gandhi GY , Nuttall GA , Abel MD , et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007; 146(4):233-243.

17.

Fowler VG Jr , Boucher HW , Corey GR , et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7): 653-665.

18.

Mascio CT , Alder JD , Silverman JA Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob Agents Chemother. 2007;51(12):4255-4260.

19.

Sader HS , Jones RN Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn Microbiol Infect Dis. 2009;65(2):158-162.